One in four Americans takes a prescribed psychotropic drug for mental health reasons. Many others take psychotropics—such as antidepressants, benzodiazepines, and opioids—for pain control, menopause discomfort, and other conditions. Yet clinicians receive virtually no training on how to safely stop these drugs in a way that avoids relapse or withdrawal symptoms.

Your donation funds the education that fills this gap. We develop evidence-based tapering protocols and certified continuing medical education that equip prescribers with essential knowledge about psychotropic deprescribing.

You’re helping create what’s been missing from psychiatry and other medical care: clear guidance to help patients safely transition off psychotropic medications when appropriate. Whether you give $50 to support research into tapering methods or $500 to fund a continuing medical education program, you’re ensuring clinicians have the knowledge to guide patients in safe drug discontinuation and progress towards better lives.

The Psychotropic Deprescribing Council relies upon your support.

Transform how medicine approaches psychotropic deprescribing. Because doctors and patients alike need safer practices and better outcomes.